BLK-Max Super Speciality Hospital in New Delhi has expanded its advanced medical services by launching a comprehensive lung transplant programme. Consequently, patients with end-stage lung disease now have access to specialized evaluation, surgery, and long-term care under one roof. Additionally, this initiative provides new hope for individuals who no longer respond to conventional medical therapy.
Key Features of the Lung Transplant Programme
End-stage respiratory conditions often require advanced surgical interventions when medical treatments fail to sustain lung function. For instance, conditions like interstitial lung disease (ILD), chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis severely impair a patient’s quality of life. Furthermore, patients suffering from pulmonary hypertension and bronchiectasis can also benefit from this specialized surgical approach. Therefore, the program integrates ECMO support and modern critical care infrastructure to handle high-risk surgical cases successfully.
Multidisciplinary Leadership and Expert Care
Dr. Pramoj Jindal leads the multidisciplinary surgical team as Senior Director of Thoracic Surgery & Lung Transplantation. In addition, the specialized clinical team includes pulmonologists, transplant physicians, intensivists, and cardiac anaesthetists. Rehabilitation specialists, physiotherapists, infectious disease experts, and transplant coordinators also collaborate to manage patient recovery. As a result, patients receive seamless clinical monitoring before, during, and long after their surgical procedure. Ultimately, this comprehensive strategy aims to restore breathing capability and significantly extend patient survival.
Frequently Asked Questions
Q1: What conditions qualify for evaluation under the lung transplant programme?
Doctors evaluate patients with end-stage lung diseases such as ILD, severe COPD, pulmonary fibrosis, and pulmonary hypertension. Specifically, candidates include individuals whose conditions no longer respond to oxygen therapy or conventional pharmacological treatments.
Q2: Who leads the multidisciplinary lung transplant team at BLK-Max Hospital?
Dr. Pramoj Jindal, Senior Director of Thoracic Surgery & Lung Transplantation, leads the multidisciplinary clinical team. Moreover, the team features pulmonologists, intensivists, cardiac anaesthetists, physiotherapists, and transplant coordinators working together.
Q3: How does lung transplantation improve quality of life for end-stage respiratory patients?
Lung transplantation replaces diseased pulmonary tissue to restore normal respiratory mechanics and adequate systemic oxygenation. Consequently, patients experience improved functional capacity, reduced breathlessness, and enhanced long-term survival prospects.
Explore Further
For medical professionals seeking to expand their expertise in respiratory health and critical care, exploring specialized Pulmonology Speciality Courses can provide invaluable clinical insights.
References
- Max launches transplant programme to advance lung cancer care – ETHealthworld
- BLK-Max introduces multidisciplinary lung transplant programme for end-stage lung disease – ETHealthWorld
- Thoracic Surgery & Lung Transplant Hospital in Delhi, India – BLK-Max Super Speciality Hospital
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.